SCHEMBL3256289

SCHEMBL3256289

CC(=O)NCCNc1cc(N2CCN(C(=O)c3ccc(Br)c(C)c3)CC2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.44
MGLL Q99685 4/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
SLC6A7 Q99884 1/20 0.39
HDAC1 Q13547 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HSD17B10 Q99714 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
USP2 O75604 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
KDM2B Q8NHM5 2/20 0.38
KDM6B O15054 1/20 0.38
NR1I2 O75469 1/20 0.38
CHRNA1 P02708 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166838 0.92 MGLL (0.49) GBA1MGLLMAPTALDH1A1KDM4E
SCHEMBL3165387 0.89 GBA1 (0.45) GBA1MGLLMAPTALDH1A1KDM4E
SCHEMBL3164315 0.89 GBA1 (0.50) GBA1MGLLMAPTALDH1A1KDM4E
SCHEMBL3174398 0.88 GBA1 (0.48) GBA1MGLLMAPTALDH1A1KDM4E
SCHEMBL3162300 0.88 MGLL (0.45) GBA1MGLLALDH1A1HPGDSLC6A7
SCHEMBL3166449 0.87 GBA1 (0.49) GBA1MGLLMAPTALDH1A1KDM4E
SCHEMBL3174564 0.86 GBA1 (0.50) GBA1MGLLALDH1A1SLC6A7HSD17B10
SCHEMBL3164890 0.86 AKR1C3 (0.47) GBA1MAPTALDH1A1KDM4EHPGD
SCHEMBL3156444 0.86 GBA1 (0.46) GBA1MAPTALDH1A1KDM4EHPGD
SCHEMBL3172676 0.86 GBA1 (0.43) GBA1MGLLMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed